Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2271
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPNet Sales9,628¥ millionYear on year -3.9%
Operating profit255¥ millionYear on year +99.0%
Ordinary income890¥ millionYear on year +42.2%
Net income attributable to owners of the parent-2,271¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Net income per share△¥163.88
Operating Margin2.7％
Financial position at period-end
Total assets54,045¥ million
of which net assets 46,345 ¥ millionEquity ratio 85.8%vs. prior year-end -0.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+294
Investment+2,431
Financials-628
Net change+2,097
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥5,149 million
Segment revenueYomeishu-related business ¥8,198,260 thousand (YoY -6.5%), Kurasuwa-related business ¥1,429,845 thousand (YoY +14.2%)
Segment profitYomeishu-related business ¥2,483,827 thousand, Kurasuwa-related business ¥-710,713 thousand
Outlook and shareholder returns
Full-year earnings forecast
Period CoveredFiscal year ending March 2027
Net SalesNot disclosed (as the Company is scheduled to be delisted)
Operating profitNot disclosed (as the Company is scheduled to be delisted)
Ordinary incomeNot disclosed (as the Company is scheduled to be delisted)
Net incomeNot disclosed (as the Company is scheduled to be delisted)
Year-on-year changeNot disclosed
Annual Dividend Forecast¥45 → ¥0（-100.0%）
Factors Behind Changes in Business Performance
The factors were the decline in sales of Yomeishu (medicinal liqueur) from the previous year, the review of promotional activities for Yomeishu in Japan, and the recognition of impairment losses related to the Kurasuwa-related business and advisory fees and other expenses associated with going private.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Material subsequent eventsThe tender offer by 株式会社レノ was completed, and the company acquired 6,920,500 shares on 15 April 2026. 株式会社レノ became the parent company, and a share consolidation, abolition of the share unit system, amendments to the articles of incorporation and cancellation of 2,576,618 treasury shares are planned. The Company is scheduled to be delisted on 18 June 2026.
Impairment loss¥2,998,156 thousand: ¥2,984,900 thousand at stores and other facilities in the Kurasuwa-related business, and ¥13,256 thousand for manufacturing equipment in Nagano Prefecture. The assets subject to impairment were buildings, structures, land, machinery and equipment, tools, furniture and fixtures, trademarks and other assets.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥413,671 thousand, Gain on sale of non-current assets ¥1,656 thousand / Extraordinary loss Loss on sale of fixed assets ¥1,658 thousand, Loss on Disposal of Fixed Assets ¥13,571 thousand, Impairment Losses ¥2,998,156 thousand, Advisory fees ¥391,160 thousand, Provision for doubtful accounts for affiliated companies ¥76,499 thousand, Impairment Losses on Shares of Affiliates ¥56,919 thousand, Loss on closure of stores ¥24,704 thousand
Depreciation and amortization¥826,506 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End16,500,000
Treasury Shares at Period-End2,637,315
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥9,628 million (YoY -3.9%) |
| Operating profit | ¥255 million (YoY +99.0%) |
| Ordinary income | ¥890 million (YoY +42.2%) |
| Profit attributable to owners of the parent | ¥-2,271 million |
| Net income per share | △¥163.88 |
| Operating Margin | 2.7％ |
| Equity ratio | End of the current fiscal period 85.8％ / End of previous period 86.1％ |
| Total assets | ¥54,045 million |
| Net assets | ¥46,345 million |
| Cash flows from operating activities | ¥294 million |
| Cash flows from investing activities | ¥2,431 million |
| Cash flows from financing activities | ¥-628 million |
| Cash and cash equivalents at end of period | ¥5,149 million |
| Full-year earnings forecast | Period Covered Fiscal year ending March 2027 / Net Sales Not disclosed (as the Company is scheduled to be delisted) / Operating profit Not disclosed (as the Company is scheduled to be delisted) / Ordinary income Not disclosed (as the Company is scheduled to be delisted) / Net income Not disclosed (as the Company is scheduled to be delisted) / Year-on-year change Not disclosed |
| Annual Dividend Forecast | ¥45 → ¥0（-100.0%） |
| Segment revenue | Yomeishu-related business ¥8,198,260 thousand (YoY -6.5%), Kurasuwa-related business ¥1,429,845 thousand (YoY +14.2%) |
| Segment profit | Yomeishu-related business ¥2,483,827 thousand, Kurasuwa-related business ¥-710,713 thousand |
| Depreciation and amortization | ¥826,506 thousand |
| Impairment loss | ¥2,998,156 thousand: ¥2,984,900 thousand at stores and other facilities in the Kurasuwa-related business, and ¥13,256 thousand for manufacturing equipment in Nagano Prefecture. The assets subject to impairment were buildings, structures, land, machinery and equipment, tools, furniture and fixtures, trademarks and other assets. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥413,671 thousand, Gain on sale of non-current assets ¥1,656 thousand / Extraordinary loss Loss on sale of fixed assets ¥1,658 thousand, Loss on Disposal of Fixed Assets ¥13,571 thousand, Impairment Losses ¥2,998,156 thousand, Advisory fees ¥391,160 thousand, Provision for doubtful accounts for affiliated companies ¥76,499 thousand, Impairment Losses on Shares of Affiliates ¥56,919 thousand, Loss on closure of stores ¥24,704 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | The tender offer by 株式会社レノ was completed, and the company acquired 6,920,500 shares on 15 April 2026. 株式会社レノ became the parent company, and a share consolidation, abolition of the share unit system, amendments to the articles of incorporation and cancellation of 2,576,618 treasury shares are planned. The Company is scheduled to be delisted on 18 June 2026. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 16,500,000 |
| Treasury Shares at Period-End | 2,637,315 |
| Factors Behind Changes in Business Performance | The factors were the decline in sales of Yomeishu (medicinal liqueur) from the previous year, the review of promotional activities for Yomeishu in Japan, and the recognition of impairment losses related to the Kurasuwa-related business and advisory fees and other expenses associated with going private. |
Items this document does not state (6)
Revision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogChanges in the scope of consolidation
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales declined as sales of Yomeishu (medicinal liqueur) fell below the previous year, while operating profit increased following a review of promotional activities for Yomeishu in Japan. The Company recorded a net loss for the period because it recognized impairment losses related to the Kurasuwa-related business and advisory fees and other expenses associated with going private as extraordinary losses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.